A new startup used the versatility of plastics to bring an eye-dropping change to the medical industry with the first parts ready to deliver to customers this summer.
In 2017, Allisa Song, a current medical student at the Mayo Clinic in Minnesota, read a ProPublica investigative story detailing how drug companies make eyedrops too large for the human eye, and as a result consumers have hundreds of dollars worth of medication dripping down their face, wasted.
"Not only is it annoying, but that little bit drips down and adds to the financial barrier for those who are spending hundreds on higher-end prescriptions," she told Plastics News in a recent interview.
Song recruited a group of engineers and medical students — Elias Baker, an engineer and chief operating officer; Mackenzie Andrews, chief commercialization officer; and Jennifer Steger, chief scientific officer — and the Nanodropper was born. The company has since hired a team to help get the device to market.